Management of treatment-related toxicities in advanced medullary thyroid cancer
Marcia S. Brose(Sidney Kimmel Cancer Center), Robert I. Haddad(Georgetown University), Laura Q.M. Chow(The University of Texas at Austin), Jill Gilbert(Cancer Clinic), Carolyn Grande(University of Pennsylvania), Keith C. Bible(Mayo Clinic in Arizona), Francis P. Worden(Georgetown University)
Cited by 54
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926